Innovative Compression Sutures- BY OUR OWN FOGSIANS- SS34

Описание к видео Innovative Compression Sutures- BY OUR OWN FOGSIANS- SS34

Scientific Sangam 34, organized by ISOPARB Prayagraj in association with Allahabad, Patna & Association of Madhya Pradesh Obs Gyn Societies with academic partner Jagsonpal Pharma Ltd., makers of LycoRed Preg, JP Tone syrup, Divagest. This webinar is granted 3 ICOG points.

ORGANIZING CHAIRPERSON: Dr. Ranjana Khanna, Founder President ISOPARB Prayagraj
CHIEF GUEST: Dr. Manju Gita Mishra, Past President Patna Obs Gyn Society
GUESTS OF HONOUR: Dr. Kavita N. Singh, President AMPOGS 2024-26 and Dr. Rachna Dubey, Director Health & State Nodal Madhya Pradesh
SCIENTIFIC EXPERT: Dr. Manju Varma, President UPCOG 2011-12

ORGANIZING SECRETARY | CONVENORS: Dr. Amita Tripathi, Secretary ISOPARB Prayagraj and Dr. Deepti Gupta, Secretary AMPOGS 2024-26

CO-CONVENORS: Dr. Shubha Pande, President Allahabad Obs Gyn Society, Dr. Uma Jaiswal, Secretary Allahabad Obs Gyn Society, Dr. Parul G. Khanna, Communicator ISOPARB Prayagraj

SCIENTIFIC PROGRAM
SESSION 1: OBSTETRICS PRACTICE TODAY
SPEAKER: Dr. Ranjana Khanna, ICOG Governing Council Member 2021-25, Vice President FOGSI 2017
CHAIRPERSONS: Dr. Meena Samant, Vice President ISOPARB (2023-24) and Dr. Sharda Mishra, Sr. Consultant Obst & Gynae Jabalpur Obs Gyn Society

SESSION 2: EASY GEDION SUTURES
SPEAKER: Dr. Neena Gedion, Vice President AMPOGS 2024-26
CHAIRPERSONS: Dr. Monica Singh, Vice President Bhopal Obs Gyn Society and Dr. Amita Sinha, Secretary Patna Obs Gyn Society

SESSION 3: P SUTURES
SPEAKER: Dr. Padma Shukla, President Rewa Obs Gyn Society
CHAIRPERSONS: Dr. Nisha Sahu, Past President Jabalpur Obs Gyn Society and Dr. Ranjana Sinha, Executive Member ISOPARB

Jagsonpal presents LycoRed Preg Sachet, JP Tone iron syrup and Divagest range of natural progesterone and many more brands.
Connect us on:
YouTube:    / @jagsonpalmedicalinsights2757  
Facebook:   / jagsonpalpharmaceuticals  
LinkedIn:   / jplmed  
Twitter: https://twitter.com/jagsonpalpharma?l...

Комментарии

Информация по комментариям в разработке